|
Volume 271, Number 50,
Issue of December 13, 1996
pp. 32048-32056
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Characterization of the Promoter of the Rat Sarcoplasmic
Endoplasmic Reticulum Ca2+-ATPase 1 Gene and Analysis
of Thyroid Hormone Responsiveness*
(Received for publication, February 21, 1996, and in revised form, July 30, 1996)
Warner S.
Simonides
¶ ",
Gregory A.
Brent
¶ ,
Marc
H. M.
Thelen
,
C. Gerard
van der Linden
,
P. Reed
Larsen
¶ and
Cornelis
van Hardeveld
From the ¶ Thyroid Division, Brigham and Women's
Hospital, Department of Medicine, Harvard Medical School,
Boston, Massachusetts 02115 and the Laboratory for
Physiology, Cardiovascular Research Institute, Vrije Universiteit,
Amsterdam 1001 BT, The Netherlands
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Relaxation of skeletal muscle requires the
re-uptake of Ca2+, which is mediated by the sarcoplasmic
reticulum Ca2+-ATPase (SERCA). Thyroid hormone
(T3) stimulates the expression of the SERCA1 isoform, which
is essential for fast skeletal muscle fiber phenotype. We have cloned
and studied the first 962 base pairs of the 5 -flanking region of the
rat SERCA1 gene. This sequence was tested for T3-regulated
expression in transient transfection experiments using COS7 cells and
for binding of thyroid hormone receptor (TR) in mobility shift
assays. A construct of the 5 -flanking region and a reporter gene was
unresponsive to T3 in the absence of co-transfected thyroid
hormone receptor. In the presence of TR , a T3 induction
ratio of almost 4.0 was found, and this induction ratio was doubled
with co-transfection of an RXR expression plasmid. Analysis of
progressive 5 -deletion fragments of the sequence indicated multiple
regions involved in T3 responsiveness. Three regions, R1,
R2, and R3, were identified that bound TR complexes in mobility shift
assays and conferred T3 responsiveness to a heterologous
promoter. The most potent of these thyroid hormone response elements,
R3, increased the 2-fold background T3 stimulation of the
thymidine kinase promoter to nearly 6-fold. Detailed analysis of this
element showed that four TR-binding half-sites, comprising two
independent thyroid hormone response elements, interact cooperatively to give the maximal T3 response. T3 regulation
of SERCA1 expression is mediated by a complex thyroid hormone response
element that may serve to provide a greater range of response in
interaction with nuclear receptor partners or cell-specific
transcription factors.
INTRODUCTION
Depolarization of skeletal muscle triggers the release of
Ca2+ from the sarcoplasmic reticulum
(SR),1 activating the contractile
machinery. Relaxation requires the re-uptake of Ca2+, and
this is mediated by the SR Ca2+-ATPase (EC 3.1.6.38). Three
different genes (SERCA1, -2, and -3) encode multiple isoforms of this
Ca2+ pump (1, 2, 3, 4) of which SERCA1 and SERCA2a are the
predominant isoforms found in skeletal muscle (5, 6, 7, 8, 9, 10). SERCA1 is
expressed at a level up to 8-fold higher than SERCA2a (8, 11, 12, 13, 14) and is consequently part of the fast phenotype of skeletal muscle fibers,
characterized by high rates of relaxation and contraction. In contrast,
SERCA2a is the predominant isoform found in slow skeletal muscle fibers
(7, 9, 10).
It is now well established that thyroid hormone (T3) plays
an important role in the development and maintenance of the fast phenotype. During neonatal development of fast muscle, T3
stimulates a massive increase in SERCA1 expression (15), as well as the expression of fast isoforms of a number of contractile proteins (16, 17, 18, 19). Furthermore, in adult slow skeletal muscle sufficient levels
of T3 can induce a shift from a slow to a fast phenotype
(7, 20, 21, 22, 23). For example in rat soleus muscle, T3
stimulation (hypo- to hyperthyroidism (13, 14, 24, 25, 26, 27)) produces a
7-fold increase in total SR Ca2+-ATPase, almost all due to
induction or stimulation of expression of SERCA1 in all fibers of this
muscle (5, 7). Therefore, the SERCA1 isoform is the primary target for
T3 in the development of fast relaxation properties in
skeletal muscle. Subsequent work indicated that T3 acts at
a pretranslational level, both in neonatal development and in adult
muscle (5, 28), and a direct action of T3 was indicated by
studies using the skeletal muscle cell line L6 (29, 30). Finally,
run-on analysis established that T3 enhances the rate of
transcription of the SERCA1 gene (31).
Stimulation of transcription by T3 is mediated by nuclear
T3 receptors (TR) (32, 33, 34, 35) that recognize and bind specific
DNA sequences called thyroid hormone response elements (TRE) (36, 37, 38).
TREs act as enhancers and will confer T3 responsiveness
when inserted in a heterologous promoter. Unlike the target sequences
of other trans-acting factors, naturally occurring TREs are
remarkably variable in structure. Analysis of the TREs in several
promoters has yielded the consensus hexamer element
(A/G)GGT(C/G)A as the optimal binding site for
TR, although specific flanking nucleotides further increase affinity
(38, 39, 40, 41, 42, 43). Naturally occurring TREs typically consist of multiple
elements (half-sites) arranged as either a direct repeat spaced by 4 base pairs (DR + 4), as an inverted repeat spaced by 0 (palindrome), 1, or 2 base pairs (IR + 1/+ 2), as an inverted palindrome with a 6- or
7-base pair gap (IP + 6/+ 7), or as a combination of these in TREs
composed of three or four elements (38, 44, 45, 46, 47, 48, 49). Furthermore, a
promoter may contain several TREs contributing to the overall
T3 responsiveness (50, 51, 52). The multiple half-site
arrangement within a TRE allows for cooperative receptor binding and
dimerization or multimerization, which positively correlates with
transactivation (44, 53, 54). Deviations from the optimal hexamer
sequence and, to a lesser extent, from the optimal spacing between them
are common in naturally occurring TREs and are responsible for large
differences in TR binding affinity and transactivation potency (44).
Depending on the structure of a TRE, TR binding and transactivation can
be increased by heterodimerization with a class of apparently
ubiquitous nuclear proteins of which the retinoid X receptor (RXR) is a
major representative. RXR augments TR binding to most TREs and
potentiates T3 induction with no requirement for its
natural ligand (9-cis-retinoic acid) (55, 56, 57, 58, 59, 60). Finally,
interactions of other transcription factors with single TRs bound to
single half-sites have been described, further increasing the potential
of T3 to modulate gene transcription (55, 61).
We present an analysis of the first 962 base pairs of the 5 -upstream
region of the rat SERCA1 gene, which constitutes a functional, T3-inducible promoter. The T3 responsiveness
appears to be mediated by two weak and one strong TRE. A detailed
analysis of the strong TRE indicates an unusual array of half-sites,
four of which are required for optimal transactivation. This complex
arrangement has important implications for T3 gene
regulation.
MATERIALS AND METHODS
Isolation and Characterization of the 5 -Flanking Region of the
SERCA1 Gene
Unless otherwise indicated all molecular and
biological assays were carried out using standard methods (62). A rat
(Sprague-Dawley, adult) genomic library in EMBL-3 (Clontech),
consisting of 2.3 × 106 independent clones, was
screened with the ApaI/KpnI fragment from rabbit
SERCA1 cDNA (nt 21 to +635) (gift from Dr. Jonathan Lytton,
Brigham and Women's Hospital, Boston, MA). The fragment was labeled by
random priming in the presence of [ -32P]dATP, and a
screening of approximately 1 × 106 clones yielded two
independent clones with inserts of 14 and 15 kb. Secondary screening of
the clones using -32P-end-labeled synthetic
oligonucleotides corresponding to the 5 -nontranslated sequences of the
cDNAs of rat SERCA2a (5 -GAGTGCAGGCGGAGGCGAGGAGGC-3 ) (63) and the
non-muscle Ca2+ pump isoform SERCA3
(5 -TCAAGTTCGCAGCATTCTGCACAGT-3 ) (1) proved negative. The clones were
characterized by Southern analysis of restriction fragments using
various rat SERCA1 cDNA fragments as probes and an oligonucleotide
complementary to the 5 -nontranslated sequence of the SERCA1 cDNA
(5 -GGGGGTGATGTATTCCTTCTTA-3 ). A 3.2-kb
SacI-SacI fragment that hybridized to both a
5 -cDNA fragment ( 65 to +118 (SacI), +1 is the
translation initiation site) and the oligonucleotide was cloned into
pTZ19U (pTZ19U/Sac3.2) and analyzed by restriction enzyme digestions. A
3 SphI-SacI fragment of 1.5 kb was subcloned and
sequenced on both strands by the dideoxy chain termination method using
synthetic oligonucleotides as primers.
Determination of the Transcription Initiation Site
A
synthetic oligonucleotide (5 GGGGGTGATGTATTCCTTCTTA-3 ) derived from
the 5 -noncoding sequence of the rat SERCA1 cDNA, 44 nt upstream of
the translation initiation site, was used in the primer extension
assay. The primer was end-labeled with [ -32P]dATP and
T4 kinase (Pharmacia Biotech Inc.) and hybridized at 55 °C overnight to approximately 15 µg of total RNA, isolated from
gastrocnemius muscle of 6-week-old rats by the guanidinium thiocyanate
method (64). In this muscle, SERCA1 is expressed at a high level and
its message comprises over 95% of total SR Ca2+-ATPase
mRNA (5). Primer extension using reversed transcriptase (Life
Technologies, Inc.) was performed for 1 h at 37 °C in the presence of actinomycin D and analyzed on a 5% denaturing
polyacrylamide sequencing gel.
The probe used in the mung bean nuclease method was synthesized from a
single-stranded M13 DNA template containing an approximately 900-nt
RNA-like PstI ( 335 nt from the ATG start site)
-SacI fragment subcloned from the SERCA1 genomic clone
pTZ19U/Sac3.2 (see above). The above-described synthetic
oligonucleotide was used as a primer in the synthesis of the
complementary DNA strand in the presence of
[ -32P]dATP. After digestion with PstI, the
single-stranded primer PstI fragment was separated on a 5%
denaturing polyacrylamide gel. The position of the fragment was
determined by autoradiography, and the fragment was cut from the gel
and electro-eluted. Of this fragment, 2-4 × 105 cpm
was used as a probe and hybridized overnight with approximately 15 µg
of total RNA at 40 °C in 70% formamide. The nuclease reaction was
performed using 30, 100, and 300 units of mung bean nuclease (Promega)
for 2 h at 37 °C, and fragments were analyzed on a 5% denaturing polyacrylamide sequencing gel.
Plasmid Construction and Transient Transfection
Seven
fragments with consecutive 5 -ends at 962, 584, 490, 327,
269, 220, and 141 and a common 3 -end at +91 (+1 is the
transcription initiation site) were obtained from pTZ19U/Sac3.2 using
available restriction sites in combination with polymerase chain
reaction using synthetic oligonucleotide primers with attached restriction sites. These were cloned upstream of the chloramphenicol acetyltransferase (CAT) gene in the polylinker site of the promoterless expression vector pOCAT2 (65). The constructs were sequenced to check
the fidelity of the polymerase chain reactions. Synthetic double-stranded oligonucleotides with either BamHI or
XbaI ends and comprising wild type or mutated TRE sequences
were inserted in the appropriate restriction site upstream of the
thymidine kinase promoter in the CAT expression vector pUTKAT3 (65).
Transfections of COS7 cells using the calcium-phosphate precipitation
method were carried out as described previously (66). Transfections were done in pairs, and a mix for two plates (6 cm diameter) included 20 µg of CAT expression plasmid and 6 µg of pTKGH or pCMV- Gal. The latter two plasmids constitutively express human growth hormone and
-galactosidase, respectively, and were used to correct for differences in transfection efficiency between plates. Where
appropriate, expression plasmids (CDM8) for mouse TR 1 and human
RXR (gift of Drs. D. Mangelsdorf and R. Evans, Salk Institute, La
Jolla, CA) or mouse RXR (gift from Dr. Keiko Ozato, NIH, Bethesda,
MD) were present at 1 µg. Cell culture medium with or without 50 nM T3 was made with charcoal-stripped serum.
CAT activities (overnight incubations) were determined with the phase
extraction method (67) and expressed relative to the level of human
growth hormone or -galactosidase activity. The presented
T3 induction ratio's are the mean CAT/human growth hormone
(or Gal) levels of T3-treated to untreated plates,
performed in duplicate, of at least four independent transfections.
Statistical significance of differences between groups was calculated
using Student's two-sided t test.
Mobility Shift DNA Assay
Gel shift experiments were carried
out with purified chicken TR (cTR ). The isolation of receptor
following overexpression in Escherichia coli BL21 DE3 pLYSs
and conditions for gel shift experiments have been described before
(53). The double-stranded oligonucleotides comprising TREs, or
fragments thereof, used in the construction of pUTKAT3 plasmids were
labeled by Klenow fill-in reaction using [32P]dTTP and
gel-purified. Labeled probe (15-25,000 cpm, 4.5-7.5 fmol) was
incubated with cTR (15-200 fmol) in 30 µl containing 100 ng of
poly(dI-dC), 88 mM KCl, 10% glycerol, 25 mM
Tris-HCl, 500 µM EDTA, 0.05% Triton X-100, 10 mM -mercaptoethanol, 20 nM T3,
and 5 µg of bovine serum albumin. The binding reactions were incubated for 30 min at room temperature and analyzed at 4 °C on a
5% nondenaturing polyacrylamide gel in low ionic strength buffer (10 mM Tris-HCl, 7.5 mM glacial acetic acid, and 40 mM EDTA, pH 7.8) and electrophoresed at 500 V in the same
buffer with constant circulation. Gels were dried under vacuum and
autoradiographed for 5-15 h. Receptor binding was quantified by laser
densitometry (Pharmacia) of autoradiographs exposed for various
periods. The assignment of monomer and dimer bands for a given TRE
(fragment) was done by comparison with the characterized patterns of
shifts of rGH or lysozyme silencer TREs run on the same gel. The
fraction of TRE bound by TR monomer, dimer, or oligomer was calculated by dividing the density of a given band by that of the sum of all
retarded bands and free probe. The data shown are representative of at
least two independent experiments.
RESULTS
Isolation and Characterization of the 5 -Flanking Region of the
SERCA1 Gene
A rat genomic DNA library in EMBL3 was screened
with a rabbit SERCA1 cDNA fragment, as described under "Materials
and Methods," and two independent clones ( 8 and 17) with 14- and 15-kb SERCA1 inserts were isolated. These inserts overlapped
significantly, with the most 5 -situated insert ( 8) containing
greater than 6 kb of sequence upstream of the transcription initiation
site (Fig. 1A). A 1.5-kb
SphI-SacI fragment was subcloned and sequenced. Comparison with rat cDNA and rabbit SERCA1 genomic sequences (68) revealed that this fragment contained part of the first intron, the
first exon, and 962 base pairs of sequence upstream of the transcription initiation site.
Fig. 1.
Characterization of the 5 -flanking sequence
of the rat SERCA1 gene. A, isolation of 8 is described
under "Materials and Methods." The approximate position of
restriction endonuclease sites in the 14-kb genomic insert is
indicated. The bottom part of panel A gives the
SphI-SacI fragment that was subcloned into pTZ19U. The restriction sites used in further subcloning for sequencing purposes are indicated, and horizontal arrows show the
partially overlapping stretches that were sequenced, also using
synthetic oligonucleotides as primers. The transcription initiation
site (+1) was determined as described in the text (see also Fig. 2), and nucleotides are numbered relative to this. Sequence comparison identified exon 1 (filled bar) and intron 1 (hatched
bar) with boundary at nt +183. Panel B presents the
SERCA1 5 -flanking region, sequenced on both strands, from nt 962 to
nt +106. The transcription start site is marked by an open
arrow, and canonical promoter sequences (TATA and CCAAT) are
circled. The 5 -ends of the fragments used in this study are
indicated by arrowheads at nt 584, 490, 327, 269,
220, and 141. A possible NF-1 site
(TGG(N)7CCA) is
underlined, sequences corresponding to the E-box motif
(CANNTG) are boxed, and those
corresponding to the consensus TR-binding hexamer
((A/G)GGT(C/G)A) are marked by horizontal arrows.
[View Larger Version of this Image (41K GIF file)]
The rat SERCA1 5 -genomic sequence from 962 to +106 (sequenced on
both strands) is shown (Fig. 1B). The transcription
initiation site, or cap site of the mRNA, was mapped to a thymidine
at 184, rather than to the guanidine two positions downstream as
reported for the rabbit (68). Mapping was performed by primer extension analysis using a primer derived from the 5 -noncoding sequence, as well
as by mung bean nuclease mapping using the same primer (see
"Materials and Methods"). The product of a sequence analysis of the
genomic fragment, using the 5 -noncoding primer, was run alongside the
product of both the primer extension and the nuclease mapping in an
electrophoretic gel. This allowed unequivocal identification of the
T-residue at 184 as the 5 -end (Fig. 2), and adds 18 bases to the previously published 5 -untranslated region of the rat SERCA1 message (6). The first 200 base pairs of the rat SERCA1 5 -flanking region were 90% identical to the same region in the rabbit
gene (68). A TATA-like sequence (CATAA) was found at position 28 and
a CCAAT box at position 78. Further sequence inspection revealed a
possible NF-1 binding site
(TGG(N)7CCA) at position 192,
several E-boxes (CANNTG), which bind myogenic
factors like MyoD and myogenin (reviewed in Ref. 69), and five
TR-binding hexamers corresponding to the consensus sequence
(A/G)GGT(C/G)A (Fig. 1B).
Fig. 2.
Mapping of the 5 -end of rat SERCA1 mRNA.
Left panel, mung bean nuclease mapping. Lane 1, free probe control; lane 2, labeled (single-stranded) probe
not hybridized with RNA, and subjected to mung bean nuclease treatment
as described under "Material and Methods" (nuclease control).
Lanes 3-5, probe hybridized with RNA and treated with
decreasing nuclease concentrations; lane 3, 300 units;
lane 4, 100 units; lane 5, 30 units. Right
panel, primer extension analysis. Lane 1, primer
extension analysis using total RNA and a 32P-labeled
synthetic oligonucleotide as described under "Material and
Methods." GATC lanes, in both panels, dideoxy
sequencing lanes of pTZ19U/Sac3.2 with the described oligonucleotide
(see "Material and Methods") electrophoresed alongside the nuclease
and primer extension analyses on the same gel. The arrowhead
indicates the free probe signal; the arrow indicates the
location of the major primer extension and nuclease products.
[View Larger Version of this Image (82K GIF file)]
Analysis of T3 Responsiveness of the SERCA1
Promoter
A series of fragments with progressive 5 -deletions and
a common 3 -end (at position +91), comprising between 962 and 141 base
pairs of 5 -sequence (see Fig. 1B), were cloned upstream of
the chloramphenicol acetyltransferase (CAT) gene in the promoterless expression vector pOCAT2, placing the CAT gene under control of the
SERCA1 promoter fragment. COS cells were used in the subsequent transient transfection assays, since these cells constitute a well
characterized and sensitive system for the analysis of T3 responsiveness. Transfection assays indicated that the minimal construct ( 141), containing the CCAAT and TATA box, constitutes a
functional promoter as it directed 4-fold higher CAT expression as
compared with the pOCAT2 control plasmid. Constructs including additional 5 -sequence displayed similar or somewhat lower activities. None of the constructs showed T3 responsiveness in the
functionally TR-deficient COS cells. Co-transfection of a mouse TR
expression plasmid, however, induced T3 responsiveness
while reducing basal CAT expression. We observed an average 65%
reduction of basal CAT activity in all constructs with co-transfection
of TR, except for the shortest ( 141), where there was 37% inhibition
(pOCAT2 basal activity was not affected by TR co-transfection). Basal activity of T3 responsive promoters has previously been
shown to be repressed by binding of unliganded TR (70, 71). CAT expression driven by the full-length promoter construct ( 962) was
stimulated almost 4-fold by 50 nM T3 and
deletion to 584 did not significantly reduce T3
induction. However, T3 responsiveness was reduced in three
discrete steps upon deletion of sequences between 584 and 490,
between 269 and 220, and between 220 and 141 (Fig.
3). The low residual T3 induction of the
141 construct of 1.27 was not significantly different from the pOCAT
control.
Fig. 3.
T3 responsiveness of SERCA1
promoter fragments. Fragments of the SERCA1 5 -flanking sequence
with various 5 -ends and a common 3 -end at +91 were inserted in the
promoterless pOCAT2 vector and analyzed for T3 induction in
transient transfection assays (see "Materials and Methods"). The
mean T3 induction ratios (±S.E.) of at least six
independent transfections per construct are shown. Fragment 0 is pOCAT2
without insert. *, significantly different from next shorter fragment
(p < 0.05).
[View Larger Version of this Image (15K GIF file)]
Analysis of Putative TREs: Receptor Binding
We inspected the
sequences in the fragments of the 5 -flanking region that conferred
T3 induction (Fig. 3). All three fragments contained
regions that closely matched known TR-binding sequences with spacing
configurations found in functional TREs. These three regions (R1, R2,
and R3) are depicted in Fig. 4, and some putative half-site hexamers forming DR, IR, or IP structures are indicated by
arrows. We tested TR binding to the three regions in
gel-shift assays. The specificity of binding was confirmed by
competition for bands with excess unlabeled oligo but not with
nonspecific DNA ( -actin). Fig. 5A shows
specific receptor binding for each region, with prominent TR homodimer
bands on the R1 and R2 elements. R2 also shows multiple higher order
oligomers, and these structures are the predominant species in R3. For
both R2 and R3, double-stranded probe is shifted at this receptor
concentration, yet a significant amount of R1 probe is not, suggesting
a lower receptor affinity for this sequence.
Fig. 4.
Putative SERCA1 TRE sequences and
transactivating activities. The sequences of three regions of the
SERCA1 promoter are shown which comprise possible TREs. Putative
TR-binding half-sites (hexamers) are underlined, and their
orientations are indicated by arrows. The sequences were
inserted upstream of the heterologous TK promoter in pUTKAT3 and
analyzed for T3 induction in transient transfection assays
(see "Materials and Methods"). The mean T3 induction
ratios (±S.E.) of at least six independent transfections of pUTKAT3
(control) and the constructs are shown. *, significantly different from
pUTKAT3. **, significantly different from Region 1 and Region 2 (p < 0.05).
[View Larger Version of this Image (13K GIF file)]
Fig. 5.
Binding of TR to putative TRE's R1, R2,
and R3. A, double-stranded elements R1, R2, and R3 (see Fig.
4) were 32P-labeled and incubated with 50 fmol of E. coli-expressed cTR either without competitor, with 400-fold
molar excess of cold element, or -actin DNA, and the products were
analyzed on a nondenaturing polyacrylamide gel (see "Materials and
Methods"). Bands corresponding to free probe, TR monomer, dimer, and
oligomers are indicated. B, to assess the relative affinity
of the three elements, R3 was incubated as above but with increasing
amounts of cold competitor DNA, i.e. a 10-, 40-, 120-, or
400-fold molar excess of R3 itself, R2, or R1.
[View Larger Version of this Image (73K GIF file)]
To obtain a better estimate of the relative affinity for TR of the
three regions, labeled R3 probe was incubated with TR in the
presence of increasing amounts of unlabeled competitor probe, either
R3, R2, or R1. The results depicted in Fig. 5B suggest that
R2 is a stronger competitor than R3, whereas R1 is less potent (note
the disappearance of the dimer band). The order of receptor affinity of
the three regions is therefore R2 > R3 > R1.
Analysis of Putative TREs: Transactivation
We then tested
whether the R1, R2, and R3 elements conferred T3
responsiveness to a heterologous promoter. Each region was cloned
upstream of the viral thymidine kinase promoter driving the CAT gene in
pUTKAT3. Fig. 4 summarizes the T3 induction ratios of these
constructs. The pUTKAT3 control displayed a 2-fold background induction
in agreement with previous observations (44, 66). Insertion of the R1
or the R2 elements resulted in a significant, yet small increase in
T3 responsiveness to 3-fold. In contrast, R3 conferred an
almost 6-fold T3 induction ratio. The order of potency of
transactivation of the three regions is therefore R3 R2 = R1.
Identification of Essential Half-sites in R3
The most potent
of the three TREs, R3, was analyzed in more detail. To identify the
half-sites that are essential for maximal activity of R3, we first
tested the receptor-binding characteristics and transactivating
properties of R3 and six partially overlapping fragments of this
element. Fig. 6 lists R3 and its fragments which were
named according to their half-site composition. It should be noted that
the six half-sites A-F were chosen as likely
receptor binding sites but that additional hexamer sequences are
possible. Analysis of the affinity of TR for R3 showed that at the
lowest receptor concentration (15 fmol) approximately 50% of the R3
probe (ABCDEF) was bound and migrated mostly as a dimer
complex (Fig. 7, panel A). Some higher order
complexes were already visible, and these increased in intensity at
higher concentrations of TR where three oligomeric species could be
discerned. The relative contribution of the various complexes to the
total amount of probe bound is shown in Fig. 7, panel B.
Similar analysis of the 5 -half of R3, comprising the putative
half-sites ABCD, indicated high affinity dimer binding but no
oligomeric species, even at the highest concentration of TR (Fig.
8. panel A). Further truncation of this
sequence, leaving BCD, greatly reduced receptor affinity, but dimers
were still formed. Analysis of dimer binding to the ABCD and BCD
fragments is depicted in panel B of Fig. 8 showing the
cooperative nature of binding (sigmoidal curves) and the higher affinity with inclusion of half-site A. These results suggest that the
IR + 2 formed by B and D allows for low affinity dimer binding. High
affinity receptor binding is supported by the 5 -end of R3, possibly by
dimer formation on the IP + 6 formed by A and C. However, alternative
dimer complexes, possibly involving the ultimate 5 -hexamer sequence of
R3, could not be ruled out. The T3 induction ratio
conferred by fragments ABCD and BCD was the same and significantly
lower than R3 (Fig. 6). Both truncated R3 sequences can therefore
function as a TRE, but the 3 -half of R3 is clearly required for
maximal activity.
Fig. 6.
Analysis of functional half-sites in Region
3. Sequence of R3 with hexamers assigned A-F. Six
fragments of R3 were synthesized and inserted upstream of the
heterologous TK promoter in pUTKAT3 and analyzed for T3
induction in transient transfection assays (see "Materials and
Methods"). The fragments are indicated in the text according to their
half-site composition. The mean T3 induction ratios
(±S.E.) of at least six independent transfections per construct are
shown. *, significantly different from pUTKAT3 control (2.1 ± 0.1). **, significantly different from fragments (p < 0.05).
[View Larger Version of this Image (20K GIF file)]
Fig. 7.
Binding of TR to Region 3. A,
32P-labeled R3 was incubated with 15, 30, 60, or 125 fmol
of cTR , and the products were analyzed on a nondenaturing
polyacrylamide gel (see "Materials and Methods"). B,
plot of the fraction of R3 bound as monomer, dimer, or oligomer and
total bound probe as a function of TR input. Band intensities of
gels as in panel A, also including shifts with 200 fmol of
cTR , were quantified by laser densitometry.
[View Larger Version of this Image (25K GIF file)]
Fig. 8.
Binding of TR to fragments of Region
3. Fragments ABCD, BCD, and EF of Region 3 presented in Fig. 6 were 32P-labeled and incubated with 15, 30, 60, or 125 fmol of cTR , and the products were analyzed on a
nondenaturing polyacrylamide gel (see "Materials and Methods").
B, plot of the fraction of fragment ABCD,
BCD, and EF as well as CDE and
DE (see Fig. 10) bound as dimer as a function of TR
input. Band intensities of gels were quantified by laser
densitometry.
[View Larger Version of this Image (41K GIF file)]
Analysis of receptor binding to the downstream half of R3 (fragment EF)
showed low affinity but cooperative dimer formation (Fig. 8,
panels A and B). Half-sites E and F are most
likely responsible for the observed binding of receptors, and the DR + 2 formed by E and F constitutes a functional TRE conferring a 3.5-fold
T3 induction ratio (Fig. 6). R3 therefore consists of an
upstream and a downstream TRE contained in fragments ABCD and EF,
respectively. Analysis of the transactivating activity of fragment
BCDEF (Fig. 6) showed that the sequence 5 of half-site B is essential
for maximal transactivating activity. Fragments that partially overlap both domains did not confer T3 responsiveness above
background (fragments DE and CDE, Fig. 6).
A mutational analysis was then done to test which of the putative
half-sites are required for transactivating activity of the complete R3
element. The core G residues in TR-binding half-sites have been shown
to be essential receptor contact points, and mutation of these
abolishes binding and functional activity (39, 40, 42, 43, 45, 52). The
data in Fig. 9 show that such mutations in either
hexamer A (mut-A) or C (mut-C) abolished the function of the upstream
domain, i.e. the remaining T3 induction ratio was not different from that conferred by fragment EF (Fig. 6). Construct mut-BD showed that half-sites B and D are not required for
activity (Fig. 9). Finally, constructs mut-E and mut-F showed that
hexamers E and F are equally essential for activity of the downstream
domain, and consequently for maximal activity of R3.
Fig. 9.
Functional analysis of putative half-sites in
Region 3. Sequence of wild type R3 and mutant elements are
presented. Mutated nucleotides are in boldface and
underlined. Elements were synthesized and inserted upstream
of the heterologous TK promoter in pUTKAT3 and analyzed for
T3 induction in transient transfection assays (see
"Materials and Methods"). The mean T3 induction ratios (±S.E.) of at least eight independent transfections per construct are
shown. The background T3 induction ratio obtained with the pUTKAT3 control (2.0 ± 0.1) was taken as base line in this graph. All values were significantly different from this control. *, significantly different from R3 (p < 0.05).
[View Larger Version of this Image (24K GIF file)]
Concerning the interaction between the functional domains in R3, the
data suggest that the downstream domain (EF), because of its
considerably lower affinity (Fig. 8), will not contribute to functional
activity at limiting receptor concentration. However, we noticed that
at the lowest receptor concentration tested, where the upstream domain
ABCD should be responsible for all binding, the complete element R3
consistently bound twice as much dimer complex (compare binding
data in Fig. 7B and Fig. 8B). This indicates some
cooperative interaction between the two domains. We therefore tested
receptor binding to fragments DE and CDE, which span the central region
and partially overlap each domain. The fragment comprising half-sites
DE bound less than 14% of the probe at the highest receptor
concentration; however, this was all bound as dimers, suggesting a high
degree of cooperativity at a low overall affinity (Fig.
10). Surprisingly, the 5 -extension of this fragment with 3 base pairs, reconstituting half-site C, resulted in a similar cooperative formation of dimers, but with much higher apparent affinity
(Fig. 10). The binding data are also depicted in Fig. 8, panel
B, showing cooperativity of receptor complex formation, especially
in case of fragment CDE.
Fig. 10.
Binding of TR to fragments of Region
3. Fragments CDE and DE of Region 3 presented in Fig. 6 were
32P-labeled and incubated with 15, 30, 60, or 125 fmol of
cTR , and the products were analyzed on a nondenaturing
polyacrylamide gel (see "Materials and Methods"). The fraction of
each fragment bound as dimer as a function of TR input is plotted in
Fig. 8B.
[View Larger Version of this Image (80K GIF file)]
Potentiation of T3 Response by RXR
Finally, we
tested whether the T3 responsiveness of the SERCA1 promoter
could be potentiated by RXR. Co-transfection of RXR or - did not
affect basal promoter activity, either in the presence or absence of TR
or T3, and both isoforms augmented T3 induction to the same extent (data not shown). As shown in Fig.
11, co-transfection of an RXR expression plasmid led to an almost
doubling of the T3 induction ratio for the two longest
constructs, i.e. 575 and 962. Deletion of R3 in
construct 490 reduced the RXR potentiation to +50%. Surprisingly,
this potentiation of the T3 induction mediated by R1 and R2
was lost upon deletion of sequences immediately upstream of element R2,
i.e. between 327 and 269.
Fig. 11.
Potentiation of T3-response by
RXR. The mean T3 induction ratios (±S.E.) are shown
for pOCAT2 and SERCA1 promoter constructs (see Fig. 3) obtained in
transient transfections with or without co-transfected RXR expression
plasmid. RXR and - potentiated the T3 response to the
same extent, and results for both were combined for this plot. The
presented data are the results of at least six independent
transfections. In the case of fragments 322 through 962, the
T3 induction ratio in the presence of RXR and TR was
significantly higher than in the presence of TR alone (p < 0.05).
[View Larger Version of this Image (39K GIF file)]
DISCUSSION
The Promoter of the SERCA1 Gene of the Rat
Cloning and
sequencing of the upstream region of the rat SERCA1 gene indicated that
the 5 -nontranslated and initial 200 base pairs of the putative
promoter are virtually identical to the rabbit SERCA1 sequence, except
that the transcription initiation site is located 2 base pairs upstream
to that reported for the rabbit (68). Comparison with the published 559 base pairs of promoter sequence of the SERCA2 gene of the rat (72)
reveals no substantial sequence similarity, although three TREs are
also thought to be responsible for T3 responsiveness in
this gene (51). The marked difference in promoter sequence between
SERCA1 and SERCA2 is in line with the different modes of
transcriptional regulation of these phenotype-specific isoforms, both
in adult and in neonatal skeletal muscle. T3 initially
stimulates expression of SERCA1 as well as SERCA2 but then represses
SERCA2 in certain muscle fibers (7, 28). Clearly, the availability of
two differentially regulated, but otherwise similar, genes allows the
skeletal muscle cell to use a broader spectrum of regulatory pathways
in governing the important Ca2+ uptake function of the
SR.
The SERCA1 promoter contains multiple E-boxes, capable of binding
myogenic transcription factors of the MyoD family (69), but no other
known cis-elements that confer or enhance muscle-specific expression, such as m-CAT, CArG, GArG, MHox, and MEF-2. Myogenic factors are not essential for function of the SERCA1 promoter used in
this study, given its activity in COS cells. However, initial
experiments with L6 myoblasts showed a severalfold higher normalized
basal expression of the full-length promoter construct as compared with
COS cells, suggesting a potential effect of muscle-specific transcription factors. Nevertheless, the observed T3
induction ratio in these experiments was similar to that found in COS
cells.2 We chose COS cells to analyze the
T3 responsiveness of the promoter in detail, because the
low transfection efficiencies and low absolute levels of CAT expression
obtained with L6 muscle cells precluded an accurate analysis in these
cells.
T3 Induction of the SERCA1 Promoter
The
TR-dependent, almost 4-fold (8-fold in the presence of RXR)
T3 induction ratio found for the full-length ( 962) SERCA1 promoter construct confirms that at least part of the transcriptional activation by T3 is mediated by upstream sequences. The
SERCA1 promoter contains several single optimal half-sites for TR
binding in the first 327 base pairs. Such binding of receptor to the
single perfect half-sites immediately downstream of the CCAAT box
( 60) and 22 base pairs downstream of the transcription initiation
site (+25) might be expected to interfere with the transcriptional machinery and could be responsible for the TR-dependent,
37% reduction of basal activity of the minimal ( 141) promoter, which
was not reversed by T3. Although typical TREs consist of
two or more half-sites, TR monomers are capable of transactivation (41,
42) also through interaction with other trans-acting
factors, such as NF-1, Sp-1, COUP-TF, and CCAAT-binding protein (55,
61). In particular, T3 induction conferred to the thymidine
kinase promoter by a single TR-binding half-site was strongly
potentiated by an NF-1 site inserted 45 base pairs downstream of this
half-site (61). In the SERCA1 promoter, the NF-1 site at 192, which
disrupts R1, is located 40 base pairs downstream of a perfect
half-site, and another such half-site is located between the NF-1 site
and the CCAAT box. Although we assume that regions R1 and R2 are
primarily responsible for the T3 response in constructs up
to 490, it is possible that additional interactions between TR
monomers and other trans-acting factors are involved in this
response. Clearly, however, R3 is responsible for the additional
T3 responsiveness of the longer constructs.
The identification of regions R1, R2, and R3 as functional TREs was
based on specific binding of TR dimers and
T3-dependent transactivation of a heterologous
promoter. Comparison of the order of affinity with potency of
transactivation shows that these parameters are not necessarily
correlated, as has been previously noted for other TREs (44, 53, 73).
The high affinity binding to R2 is most likely explained by the
presence of a perfect hexamer GGGTCA, as well as an almost perfect copy
of the extended half-site TGAGGTAACT (central T is a C in R2), shown to
be a strong TR binder (39). However, the 9-base pair gap separating
these high affinity sites makes a functional interaction less likely
(41), although a DR + 12 TRE has recently been identified in the human
type 1 deiodinase gene (52). Williams et al. (44) described
the transactivating properties of a large number of natural response
elements in the context of the TK promoter and comparison with our data
would rank R1 and R2 with the bGH, ADH3, and estrogen response
elements. All of these are weak T3 responders. R3, on the
other hand, ranks with relatively strong elements, predominantly
regulated by T3, such as that of the myosin heavy chain
gene and the rGH intronic TRE.
Whether all three TREs contribute to the total T3 response
is not known. The 4-fold T3 induction of the promoter more
than compensates for the TR-dependent repression of
activity and is therefore not the result of hormone-induced
dissociation of receptor dimers (74). Presumably, the mechanism of
transactivation involves a direct interaction of the receptor complex
with the transcription-initiation complex, possibly mediated by adaptor
proteins, as has been shown for several members of the steroid hormone
receptor superfamily, including TR (75, 76). That such a mechanism may
put a limit on the number of these interactions is suggested by
previous work in which two copies of the rGH TRE in tandem more than
doubled the T3 induction of the TK promoter, but a third
copy did not have an additional effect (77). Multiple TREs have been
identified in natural promoters (50, 51, 52), and in two cases deletion studies have shown that two TREs contribute to the total T3
responsiveness (50, 52). In view of this we suggest that the
T3 response of the full-length SERCA1 promoter construct is
the result of R3, possibly in combination with either R1 or R2, rather
than of all three regions. This conclusion is supported by a comparison of the rat and rabbit promoter structures (68). The stimulation of
SERCA1 expression by T3 is similar in rat and rabbit, but
the 5 -sequences of the rabbit and rat SERCA1 gene strongly diverge upstream of position 200. Up to position 450 in the rabbit gene, the overall similarity is less than 60% and, notably, the sequences of
R1 and R2 are not conserved. However, between positions 475 and
522, the rabbit sequence contains an almost perfect copy of R3,
except for a 3-base pair insertion in the sequence separating the
upstream and downstream domains. The essential half-sites A, C, E, and
F (see "Discussion") are either fully conserved or mutated to a
similar (half-site C) or a more optimal sequence (half-site F):
|
|
|
|
|
|
|
|
The virtually complete conservation of R3, but not of R1 and R2,
suggests a significant role for R3 as a regulatory element in the
promoter of the SERCA1 gene.
Analysis of R3
The analysis of R3 identified this sequence as
an unusual, composite TRE, consisting of an upstream IP domain and a
downstream DR domain, both of which can function as independent TREs.
This combination resembles the structure of the laminin B1 (LamB1) TRE
in which four half-sites are arranged as an upstream IP + 7, touching a
DR + 3 (46), although R3 appears to be a stronger TRE, at least when
analyzed in COS cells (78). The upstream half of R3, with multiple
potential half-sites, can in principle accommodate three likely dimer
configurations, i.e. an IR + 2 (B-D), as found in the
MHC TRE (47), an IP + 6/7 (A-C), as also found in the lysozyme
silencer (Lys-F2) (48) and myelin basic protein TREs (49), and another
IP + 6 between B and the ultimate 5 -hexamer of R3. The analysis of
receptor binding to R3 fragments (Fig. 8) indicated that the apparent
affinity of dimer binding to the B-D domain is approximately 5-fold
lower than for the IP + 6/7 domain contained in fragment ABCD. This is
in agreement with several studies showing optimal spacing for TR
binding for the IP configurations of 6-9 but 0 for the IR (palindrome) (37, 43, 73, 79, 80, 81). The mutational analysis of putative receptor
contact sites (Fig. 9) then showed that half-sites B and D are not
required for functional activity of the upstream domain but that the
core G residues in both A and C are essential. Half-site C, including
the two preceding base pairs (TAAGGTTA), is an almost
perfect copy of the octamer TAAGGTCA shown to be an optimal
TR-binding site (40). It has been shown that the PydPuo nucleotides 5
of the hexamer half-site sequence contribute considerably to affinity
and functional potency of a TRE (39, 40, 41, 42, 43, 52), and given the high
affinity dimer binding to A and C we suggest that this element is an IP + 7 (43) with an octamer sequence of half-site A of
TAGGGAGG.
Further analysis of receptor binding and transactivation by R3 mutants
identified hexamers E and F as essential half-sites forming the
downstream TRE (DR + 2) in R3. The similar effect of mutating either A,
C, E, or F on the potency of R3 (Fig. 9) indicates that functional
interaction between both domains depends on dimer formation on each.
The affinity of dimer formation for the downstream DR + 2 TRE is much
lower than for the A-C element, in agreement with previous studies
(43, 82), and it is questionable whether this element by itself would
be of relevance. The role of the downstream element appears to depend
on its capacity to interact with the upstream element. Such
potentiation of dimer binding by a third half-site is well documented
for the rGH TRE (53, 54), and this cooperativity is also observed for
the four half-sites in the LamB1 TRE, all of which are required for maximal activity (73). The data in Fig. 8 indicate that half-sites C
and E may be responsible for the interaction of the upstream and
downstream domains. Although the receptor dimer complex formed on E and
C (IR + 10) has no transactivating properties (Fig. 6), the relatively
high affinity, cooperative binding of receptors to these half-sites
could contribute to the formation of functional complexes on both
domains in the intact R3. Although dimer binding on an IR + 10 was
reported before (83), cooperativity was not observed, and it was much
weaker compared with the (optimal) palindrome structure. However, we
noticed that the heptamer CATCTGC, separating C and E, is identical to
the sequence separating both TR-binding domains in the rat
thyrotropin- TRE (84). This sequence was shown not to bind TR itself
but to be required for optimal TR binding and function of the element.
We therefore suggest that the gap sequence between half-site C and E is
responsible for the unusual high affinity of this IR + 10, thus
affecting the overall TR-binding affinity of R3.
Potentiation by RXR
Heterodimerization of TR with RXR has
been shown to increase overall binding affinity for a TRE, but
potentiation of T3 induction appears to be dependent on the
structure of the TRE (78). Nevertheless, because the RXR's are
ubiquitous, they are considered to be the principal partner of TR
in vivo. Hsu et al. (78) analyzed several natural
TREs in COS cells and showed that only the rat GH and laminin B1 TREs
show augmentation of the T3 induction ratio with RXR. They
concluded that TREs with more than 2 half-sites support potentiation of
transactivation by RXR. Our data, showing a doubling of the
T3 induction ratio of the SERCA1 promoter with RXR, are in
line with this conclusion, given the complex half-site composition of
R3.
We conclude that the T3 responsiveness of the 962-base
pair SERCA1 promoter of the rat is primarily mediated by R3. The
presence of this TRE in the promoter of the rat SERCA1 gene provides a mechanism for the T3-stimulated expression of this isoform
of the SR Ca2+-ATPase in rat skeletal muscle. The complex
arrangement of the half-sites in the R3 TRE may be required to mediate
the developmental and tissue-specific actions of T3 on
SERCA1 gene expression.
FOOTNOTES
*
This work was supported by National Institutes of Health
Grant DK 44128. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U34282[GenBank].
"
Supported by the Netherlands Organization for Scientific
Research (NWO). To whom correspondence should be addressed: Laboratory for Physiology, Cardiovascular Research Institute, Vrije Universiteit, van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. Tel.:
31204448116; Fax: 31204448255; E-mail:
ws.simonides.physiol{at}med.vu.nl.
Present address: University of California, 11301 Wilshire
Blvd., Los Angeles, CA 90073.
1
The abbreviations used are: SR, sarcoplasmic
reticulum; nt, nucleotide(s); SERCA, sarcoplasmic endoplasmic reticulum
Ca2+-ATPase; TR, thyroid hormone receptor; TRE, thyroid
hormone response elements; CAT, chloramphenicol acetyltransferase; IR,
inverted repeat; IP, inverted palindrome; DR, direct repeat; RXR,
retinoid X receptor; cTR , chicken TR ; rGH, rat growth hormone;
kb, kilobase pair(s).
2
M. H. M. Thelen, W. S. Simonides, and C. van
Hardeveld. unpublished observations.
Acknowledgments
We wish to thank Dr. Jonathan Lytton for
providing us of with cDNA of rat SERCA1, Drs. Barry Forman and
Herbert Samuels for an expression vector for chicken TR , Drs. David
Mangelsdorf and Ronald Evans for cDNA of mouse RXR , and Dr.
Keiko Ozato for cDNA of mouse RXR .
REFERENCES
-
Burke, S. E., Lytton, J., MacLennan, D. H., and Shull, G. E.
(1989)
J. Biol. Chem.
264,
18561-18568
[Abstract/Free Full Text]
-
MacLennan, D. H., Brandl, C. J., Korczak, B., and Green, N. M.
(1985)
Nature
316,
696-700
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brandl, C. J., Green, N. M., Korczak, B., and MacLennan, D. H.
(1986)
Cell
44,
597-607
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brandl, C. J., deLeon, S., Martin, D. R., and MacLennan, D. H.
(1987)
J. Biol. Chem.
262,
3768-3774
[Abstract/Free Full Text]
-
Simonides, W. S., van der Linden, G. C., and van Hardeveld, C.
(1990)
FEBS Lett.
274,
73-76
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wu, K.-D., and Lytton, J.
(1993)
Am. J. Physiol.
264,
C333-C341
[Abstract/Free Full Text]
-
Muller, A., van der Linden, G. C., Zuidwijk, M. J., Simonides, W. S., Van der Laarse, W. J., and van Hardeveld, C.
(1994)
Biochem. Biophys. Res. Commun.
203,
1035-1042
[CrossRef][Medline]
[Order article via Infotrieve]
-
Leberer, E., and Pette, D.
(1986)
Eur. J. Biochem.
156,
489-496
[Medline]
[Order article via Infotrieve]
-
Briggs, F. N., Lee, K. F., Feher, J. J., Wechsler, A. S., Ohlendieck, K., and Campbell, K.
(1990)
FEBS Lett.
259,
269-272
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jorgensen, A. O., Arnold, W., Pepper, D. R., Kahl, S. D., Mandel, F., and Campbell, K. P.
(1988)
Cell Motil. Cytoskeleton
9,
164-174
[CrossRef][Medline]
[Order article via Infotrieve]
-
Everts, M. E.
(1990)
Cell Calcium
11,
343-352
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dulhunty, A. F., Banyard, M. R., and Medveczky, C. J.
(1987)
J. Membr. Biol.
99,
79-92
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dulhunty, A. F.
(1990)
Pflügers Arch.
415,
433-439
[CrossRef][Medline]
[Order article via Infotrieve]
-
Everts, M. E., Andersen, J. P., Clausen, T., and Hansen, O.
(1989)
Biochem. J.
260,
443-448
[Medline]
[Order article via Infotrieve]
-
Simonides, W. S., and van Hardeveld, C.
(1989)
Endocrinology
124,
1145-1153
[Abstract/Free Full Text]
-
Gambke, B., Lyons, G. E., Hasselgrove, J., Kelly, A. M., and Rubinstein, N. A.
(1983)
FEBS Lett.
156,
335-339
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mahdavi, V., Izumo, S., and Nadal-Ginard, B.
(1987)
Circ. Res.
60,
804-814
[Abstract/Free Full Text]
-
Butler-Browne, G. S., Herlicoviez, D., and Whalen, R. G.
(1984)
FEBS Lett.
166,
71-75
[CrossRef][Medline]
[Order article via Infotrieve]
-
d'Albis, A., Chanoine, C., Janmot, C., Mira, J., and Couteaux, R.
(1990)
Eur. J. Biochem.
193,
155-161
[Medline]
[Order article via Infotrieve]
-
Nicol, C. J., and Bruce, D. S.
(1981)
Pflügers Arch.
390,
73-79
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nwoye, L., Mommaerts, W. F. H. M., Simpson, D. R., Seraydarian, K., and Marusich, M.
(1982)
Am. J. Physiol.
242,
R401-R408
-
Müntener, M., van Hardeveld, C., Everts, M. E., and Heizmann, C. W.
(1987)
Exp. Neurol.
98,
529-541
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fitts, R. H., Winder, W. W., Brooke, M. H., Kaiser, K. K., and Holloszy, J. O.
(1980)
Am. J. Physiol.
238,
C15-C20
[Abstract/Free Full Text]
-
Kim, D. H., Witzmann, F. A., and Fitts, R. H.
(1982)
Am. J. Physiol.
243,
C151-C155
[Abstract/Free Full Text]
-
Simonides, W. S., and van Hardeveld, C.
(1985)
Biochim. Biophys. Acta
844,
129-141
[Medline]
[Order article via Infotrieve]
-
Simonides, W. S., and van Hardeveld, C.
(1986)
Cell Calcium
7,
147-160
[CrossRef][Medline]
[Order article via Infotrieve]
-
Simonides, W. S., and van Hardeveld, C.
(1990)
Anal. Biochem.
191,
321-331
[CrossRef][Medline]
[Order article via Infotrieve]
-
van der Linden, G. C., Simonides, W. S., and van Hardeveld, C.
(1992)
Mol. Cell. Endocrinol.
90,
125-131
[CrossRef][Medline]
[Order article via Infotrieve]
-
Muller, A., van Hardeveld, C., Simonides, W. S., and van Rijn, J.
(1991)
Biochem. J.
275,
35-40
-
Muller, A., van Hardeveld, C., Simonides, W. S., and van Rijn, J.
(1992)
Biochem. J.
283,
713-718
-
Thelen, M. H. M., Muller, A., Zuidwijk, M. J., van der Linden, G. C., Simonides, W. S., and van Hardeveld, C.
(1994)
Biochem. J.
303,
467-474
-
Lazar, M. A.
(1993)
Endocr. Rev.
14,
184-193
[Abstract/Free Full Text]
-
Glass, C. K., and Holloway, J. M.
(1990)
Biochim. Biophys. Acta
1032,
157-176
[Medline]
[Order article via Infotrieve]
-
Yen, P. M., and Chin, W. W.
(1994)
Trends Endocrinol. Metab.
5,
65-72
-
Evans, R. M.
(1988)
Science
240,
889-895
[Abstract/Free Full Text]
-
Glass, C. K.
(1994)
Endocr. Rev.
15,
391-407
[Abstract/Free Full Text]
-
Desvergne, B.
(1994)
Mol. Cell. Endocrinol.
100,
125-131
[CrossRef][Medline]
[Order article via Infotrieve]
-
Williams, G. R., and Brent, G. A.
(1994)
in
Molecular Endocrinology. Basic Concepts and Clinical Correlations (Weintraub, B., ed), pp. 217-239, Raven Press, New York
-
Kim, H.-S., Crone, D. E., Sprung, C. N., Tillman, J. B., Force, W. R., Crew, M. D., Mote, P. L., and Spindler, S. R.
(1992)
Mol. Endocrinol.
6,
1489-1501
[Abstract/Free Full Text]
-
Katz, R. W., and Koenig, R. J.
(1993)
J. Biol. Chem.
268,
19392-19397
[Abstract/Free Full Text]
-
Katz, R. W., Subauste, J. S., and Koenig, R. J.
(1995)
J. Biol. Chem.
270,
5238-5242
[Abstract/Free Full Text]
-
Schrader, M., Becker-Andre, M., and Carlberg, C.
(1994)
J. Biol. Chem.
269,
6444-6449
[Abstract/Free Full Text]
-
Carlberg, C.
(1993)
Biochem. Biophys. Res. Commun.
195,
1345-1353
[CrossRef][Medline]
[Order article via Infotrieve]
-
Williams, G. R., Harney, J. W., Moore, D. D., Larsen, P. R., and Brent, G. A.
(1992)
Mol. Endocrinol.
6,
1527-1537
[Abstract/Free Full Text]
-
Brent, G. A., Harney, J. W., Chen, Y., Warne, R. L., Moore, D. D., and Larsen, P. R.
(1989)
Mol. Endocrinol.
3,
1996-2004
[Abstract/Free Full Text]
-
Vasios, G. W., Gold, J. D., Petkovich, M., Chambon, P., and Gudas, L. J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
9099-9103
[Abstract/Free Full Text]
-
Izumo, S., and Mahdavi, V.
(1988)
Nature
334,
539-542
[CrossRef][Medline]
[Order article via Infotrieve]
-
Baniahmad, A., Steiner, C., Kohne, A. C., and Renkawitz, R.
(1990)
Cell
61,
505-514
[CrossRef][Medline]
[Order article via Infotrieve]
-
Farsetti, A., Desvergne, B., Hallenbeck, P., Robbins, J., and Nikodem, V. M.
(1992)
J. Biol. Chem.
267,
15784-15788
[Abstract/Free Full Text]
-
Suzuki, S., Miyamoto, T., Opsahl, A., Sakurai, A., and DeGroot, L.
(1994)
Mol. Endocrinol.
8,
305-314
[Abstract/Free Full Text]
-
Hartong, R., Wang, N., Kurokawa, R., Lazar, M. A., Glass, C. K., Apriletti, J. W., and Dillmann, W. H.
(1994)
J. Biol. Chem.
269,
13021-13029
[Abstract/Free Full Text]
-
Toyoda, N., Zavacki, A. N., Maia, A. L., Harney, J. W., and Larsen, P. R.
(1995)
Mol. Cell. Biol.
15,
5100-5112
[Abstract]
-
Brent, G. A., Williams, G. R., Harney, J. W., Forman, B. M., Samuels, H. H., Moore, D. D., and Larsen, P. R.
(1992)
Mol. Endocrinol.
6,
502-514
[Abstract/Free Full Text]
-
Williams, G. R., Harney, J. W., Forman, B. M., Samuels, H. H., and Brent, G. A.
(1991)
J. Biol. Chem.
266,
19636-19644
[Abstract/Free Full Text]
-
Berrodin, T. J., Marks, M. S., Ozato, K., Linney, E., and Lazar, M. A.
(1992)
Mol. Endocrinol.
6,
1468-1478
[Abstract/Free Full Text]
-
Leid, M., Kastner, P., Lyons, R., Nakshatri, N., Saunders, M., Zacharewski, T., Chen, J.-Y., Staub, A., Garnier, J.-M., Mader, S., and Chambon, P.
(1992)
Cell
68,
377-395
[CrossRef][Medline]
[Order article via Infotrieve]
-
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C.
(1992)
Cell
68,
397-406
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mangelsdorf, D. J., Borgmeyer, U., and Heyman, R. A.
(1992)
Genes Dev.
6,
329-344
[Abstract/Free Full Text]
-
Zhang, X.-K., Hoffmann, B., Tran, P. B.-V., Graupner, G., and Pfahl, M.
(1992)
Nature
355,
441-446
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kliewer, S. A., Umesono, K., Mangelsdorf, D. J., and Evans, R. M.
(1992)
Nature
355,
446-449
[CrossRef][Medline]
[Order article via Infotrieve]
-
Voz, M. L., Peers, B., Wiedig, M. J., Jacquemin, P., Belayew, A., and Martial, J. A.
(1992)
Mol. Cell. Biol.
12,
3991-3997
[Abstract/Free Full Text]
-
Ausubel, F. E., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., and Struhl, K.
(eds)
(1987)
Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York
-
Lompre, A.-M., de la Bastie, D., Boheler, K. R., and Schwartz, K.
(1989)
FEBS Lett.
249,
35-41
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chomczynski, P., and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159
[Medline]
[Order article via Infotrieve]
-
Prost, E., and Moore, D. D.
(1986)
Gene (Amst.)
45,
107-111
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brent, G. A., Larsen, P. R., Harney, J. W., Koenig, R. J., and Moore, D. D.
(1989)
J. Biol. Chem.
264,
178-182
[Abstract/Free Full Text]
-
Seed, B., and Sheen, J.-Y.
(1988)
Gene (Amst.)
67,
271-277
[CrossRef][Medline]
[Order article via Infotrieve]
-
Korczak, B., Zarain-Herzberg, A., Brandl, C. J., Ingles, C. J., Green, N. M., and MacLennan, D. H.
(1988)
J. Biol. Chem.
263,
4813-4819
[Abstract/Free Full Text]
-
Olson, E. N.
(1993)
Mol. Endocrinol.
7,
1369-1378
[Free Full Text]
-
Brent, G. A., Dunn, M. K., Harney, J. W., Gulick, T., Larsen, P. R., and Moore, D. D.
(1989)
New Biol.
1,
329-336
[Medline]
[Order article via Infotrieve]
-
Graupner, G., Wills, K. N., Tzukerman, M., Zhang, X.-K., and Pfahl, M.
(1989)
Nature
340,
653-656
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rohrer, D. K., Hartong, R., and Dillmann, W. H.
(1991)
J. Biol. Chem.
266,
8638-8646
[Abstract/Free Full Text]
-
Williams, G. R., Zavacki, A. M., Harney, J. W., and Brent, G. A.
(1994)
Endocrinology
134,
1888-1896
[Abstract/Free Full Text]
-
Miyamoto, T., Suzuki, S., and Degroot, L. J.
(1993)
Mol. Endocrinol.
7,
224-231
[Abstract/Free Full Text]
-
Ing, N. H., Beekman, J. M., Tsai, S. Y., Tsai, M.-J., and O'Malley, B. W.
(1992)
J. Biol. Chem.
267,
17617-17623
[Abstract/Free Full Text]
-
Baniahmad, A., Ha, I., Reinberg, D., Tsai, S., Tsai, M.-J., and O'Malley, B. W.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8832-8836
[Abstract/Free Full Text]
-
Brent, G. A., Williams, G. R., Harney, J. W., Forman, B. M., Samuels, H. H., Moore, D. D., and Larsen, P. R.
(1991)
Mol. Endocrinol.
5,
542-548
[Abstract/Free Full Text]
-
Hsu, J., Zavacki, A. M., Harney, J. W., and Brent, G. A.
(1995)
Endocrinology
136,
421-430
[Abstract]
-
Kurokawa, R., Yu, V., Naar, A., Kyakumoto, S., Han, Z., Silverman, S., Rosenfeld, M. G., and Glass, C. K.
(1993)
Genes Dev.
7,
1423-1435
[Abstract/Free Full Text]
-
Wahlstrom, G. M., Sjoberg, M., Andersson, M., Nordstrom, K., and Vennstrom, B.
(1992)
Mol. Endocrinol.
6,
1013-1022
[Abstract/Free Full Text]
-
Glass, C. K., Holloway, J. M., Devary, O. V., and Rosenfeld, M. G.
(1988)
Cell
54,
313-323
[CrossRef][Medline]
[Order article via Infotrieve]
-
Miyamoto, T., Suzuki, S., and Degroot, L. J.
(1994)
Mol. Cell. Endocrinol.
102,
111-117
[CrossRef][Medline]
[Order article via Infotrieve]
-
Forman, B. M., Casanova, J., Raaka, B. M., Ghysdael, J., and Samuels, H. H.
(1992)
Mol. Endocrinol.
6,
429-442
[Abstract/Free Full Text]
-
Bodener, D. L., Mroczynski, M. A., Weintraub, B. D., Radovick, S., and Wondisford, F. E.
(1991)
J. Biol. Chem.
266,
21666-21673
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Ukropec, R. V. P. Anunciado, Y. Ravussin, and L. P. Kozak
Leptin Is Required for Uncoupling Protein-1-Independent Thermogenesis during Cold Stress
Endocrinology,
May 1, 2006;
147(5):
2468 - 2480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fourcade, S. Savary, C. Gondcaille, J. Berger, A. Netik, F. Cadepond, M. El Etr, B. Molzer, and M. Bugaut
Thyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)
Mol. Pharmacol.,
June 1, 2003;
63(6):
1296 - 1303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Danzi, K. Ojamaa, and I. Klein
Triiodothyronine-mediated myosin heavy chain gene transcription in the heart
Am J Physiol Heart Circ Physiol,
June 1, 2003;
284(6):
H2255 - H2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Y. Liu and G. A. Brent
A Complex Deoxyribonucleic Acid Response Element in the Rat Ca2+/Calmodulin-Dependent Protein Kinase IV Gene 5'-Flanking Region Mediates Thyroid Hormone Induction and Chicken Ovalbumin Upstream Promoter Transcription Factor 1 Repression
Mol. Endocrinol.,
November 1, 2002;
16(11):
2439 - 2451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Hadri, A. Ozog, F. Soncin, and A.-M. Lompre
Basal Transcription of the Mouse Sarco(endo)plasmic Reticulum Ca2+-ATPase Type 3 Gene in Endothelial Cells Is Controlled by Ets-1 and Sp1
J. Biol. Chem.,
September 20, 2002;
277(39):
36471 - 36478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sharma and J. D. Fondell
Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo
PNAS,
June 11, 2002;
99(12):
7934 - 7939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev,
July 1, 2001;
81(3):
1097 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mitchell-Felton and S. C. Kandarian
Normalization of muscle plasmid uptake by Southern blot: application to SERCA1 promoter analysis
Am J Physiol Cell Physiol,
December 1, 1999;
277(6):
C1269 - C1276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Peters, H. Mitchell-Felton, and S. C. Kandarian
Unloading induces transcriptional activation of the sarco(endo)plasmic reticulum Ca2+-ATPase 1 gene in muscle
Am J Physiol Cell Physiol,
May 1, 1999;
276(5):
C1218 - C1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mitchell-Felton, R. B. Hunter, E. J. Stevenson, and S. C. Kandarian
Identification of Weight-bearing-responsive Elements in the Skeletal Muscle Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA1) Gene
J. Biol. Chem.,
July 21, 2000;
275(30):
23005 - 23011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. de Meis
Uncoupled ATPase Activity and Heat Production by the Sarcoplasmic Reticulum Ca2+-ATPase. REGULATION BY ADP
J. Biol. Chem.,
June 29, 2001;
276(27):
25078 - 25087.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|